1 |
Wilson, P.W.F., Kannel, W.B., Silbershartz, H., D'Agostino, R.B. Clustering of metabolic factors and coronary heart disease. Arch Intern Med. 159: 1104-1109, 1999
DOI
ScienceOn
|
2 |
Reven, G.M. Banting lecture 1988. Role of insulin resistance in human disease. Diabetes, 37: 1595-1607, 1988
DOI
PUBMED
ScienceOn
|
3 |
H.S. Park, S.W. OH, J.H. Kang, Y.W. Park, J.M. Choi, Y.S. Kim, W.H. Choi, H.J. Yoo, Y.S. Kim. Prevalence and associated factors with metabolic syndrome in south korea-from the korean national health and nutrition examination survey 1998. Korean J of obesity(kor) 12(1):1-14, 2003
|
4 |
nternational Obesity Task Force. The Asia-Pacific perspective, Redefining obesity and its treatment. Western Pacific Region. 2000.
|
5 |
Hong, Y., Pedersen, N.L., Brismar, K., De Faire, U. Genetic and environmental architecture of the features of the insulin-resistance sydrome. Am J Hum Genet 60: 143-152, 1997
PUBMED
|
6 |
H.J. Lee, H.S. Kwon, Y.M. Park, H.N. Chun, Y.H. Choi, S.H. Ko, J.M. Lee, K.H. Yoon, B.Y. Cha, W.C. Lee, K.W. Lee, H.Y. Son, S.K. Kang, M.S. Ahn, J.M. Kang, D.S. Kim. Waist circumference as a risk factor for metabolic syndrome in Korean adult ; evaluation from 5 different criteria of metabolic syndrome(kor). J Kor Diabetes Assoc 29: 48-56, 2005
|
7 |
H.C. Jang, S. Yim, N.H. Jo. Metabolic syndrome -Korean Ansung and Ansan Cohort(KAAC) Study. Korean J Med 67 Supp(kor) 2: s528-532, 2004
|
8 |
Shepherd, J., Blauw, G.J., Murphy, M.B., Bollen, E.L., Buckley, B.M., Cobbe, S.M. Pravastartin in elderly individuals at risk of vascular disease(PROSPER): a randomized controlled trial. Lancet 360: 1623-1630, 2002
DOI
PUBMED
ScienceOn
|
9 |
Lakka, H.M., Laaksinen, D.E., Lakka, T.A. et al. The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. JAMA 288: 2709-2716, 2002
DOI
ScienceOn
|
10 |
Park, H.S., Kim, H.K., Park, K.S., Kim, S.Y., Park, Y.B., Cho, B.Y., Lee, K.L., Koh, C.S., Min, H.K., Kim, Y.I., Shin, Y.S., Paik, H.Y. Community based epidemiologic study on serum lipid profiles and their interaction with other atherosclerotic cardiovascular risk factors in Yonchon country. Korean J Lipidology(kor) 3: 191-203, 1993
|
11 |
Chen hanyang, Zhang Xiaoliang, Xiong Shangquan. Clinical Observation on the treatment of combined hyperlipidemia with Xiaotan Qingzhi Fang prescription and fluvastatin. Chin J GMCM May Vol 23(5):642-644, 2008
|
12 |
ACE position statement. Guidelindes for glycemic control. Endocr Pract 9(suppl. 1):7-19, 2003
|
13 |
Liu, S., Willett, W.C., Stampfer, M.J., Hu, F.B., Franz, M., Sampson, L., Hennekens, C.H., Manson, J.E. A prospective study of dietary glycemic load, carbohydrate intake, and risk of coronary heart disease in US women. Am J Clin Nutr 71: 1455-1461, 2000
DOI
|
14 |
Park, M.Y., Lee, K.S., Sung, M.K. Effects of dietary mulberry, Korean red ginseng, and banaba on glucose homeostasis in regulation to PPAP- , PPAP- , and LPL mRNA expression. Life Sci. 26: 3344-3354, 2005
|
15 |
Ricketts, M.L., Moore, D.D., Banz, W.J. et al. Molecular mechanism of action of the soy isoflavones includes activation of promiscuous nuclear receptors. J Nutr Biochem, 6: 321-330, 2005
DOI
PUBMED
ScienceOn
|
16 |
Grundy, S.M. A constellation of complications. The metabolic syndrome. Clin Cornerstone. 7: 36-45, 2005
DOI
ScienceOn
|
17 |
WHO(World Health Organization). Report of a WHO consultation of metabolic syndrome in definition, diagnosis, and classification of diabetes mellitus and its complications. I. Diagnosis and classification of diabetes mellitus. World Health Organization, Department of Noncommunicable Disease Surveillance. Geneva, 1999
|
18 |
Einhorn, D., Reven, G.M., Cobin, R.H., Ford, E., Ganda, O.P., Handeksman, Y., Helliman, R., Jelinger, P.S., Kendall, D., Krauss, R.M., Neufeld, N.D., Petak, S.M., Rodbard, H.W., Seibel, J.A., Smith, D.A., Wilson, P.W. American college of Endocrinology position statement on the insulin resistance syndrome. Endocr Pract, 9: 237-252, 2003
|
19 |
Alexander, C.M., Landsman, P.B., Teutsh, S.M., Haffner, S.M. NCEP-defined metabolic syndrome, diabetes, and prevalence of coronary heart disease among NHANES III participants age 50 years and older. Diabetes, 52: 1210-1214, 2003
DOI
ScienceOn
|
20 |
Liese, A.D., Mayer-Davis, E.J., Tyroler, H.A., Davis, C.E., Keil, U., Schmit, M.I., Brancati, F.L., Heiss, G. Familial components of the multiple metabolic syndrome: The ARIC study. Diabetologia 40: 963-970, 1997
DOI
ScienceOn
|
21 |
Korea ministry for health, welfare and family affairs : From the korean national health and nutrition examination survey 1998. www.mw.go.kr
|
22 |
H.S. Park, H.C. Shin, B.S. Kim, K.Y. Lee, W.S. Choi, J.A. Shin, Y.D. Nam, S.P. Bae, K.S. Chun. Prevalence and associated factors of metabolic syndrome among adults in primary care. Korean J of obesity(kor) 12(2):108-123, 2003
|
23 |
Gordon, T., Castelli, W.P., Hjotland, M.C., Kannel, W.B., Dawber, T.R. High density lipoprotein as a protective factor against coronary heart disease. The ramnigham Study. Am J MED. 62(5):707-714, 1977
DOI
ScienceOn
|
24 |
Kou, W.R. The basic and clinic research of Xuezhikang. Chni Prescrip Drug(chin) 7: 52-57, 2005
|
25 |
Fan, C.L., Wo, X.D., Luo, Y. et al. Effect of curcumin on expression of human lymphocytes, Chin Phar J(chin) 40(13):980-983, 2005
|
26 |
Youl Lee Lym, Seung Wook Hwang, Hyun Jun Shim, Eun Hye Oh, Yoo Soo Chang, Be Long Cho. Prevalence and Risk Factors of the Metabolic Syndrome as Defined by NCEP-ATP III. J Korean Fam Med(kor), 24(2):135-143, 2003
|
27 |
K.H. Lee, J.C. Son, B.T. Kim, B.H. Choi, J.S. Hye, C.K. Cha, J.Y. Choi, Y.J. Lee, Y.H. Ahn. Non-HDL Cholesterol as a risk factor of metabolic syndrome in Korean women. Korean J of obesity(kor). 16(3):102-110, 2007
|
28 |
Isomaa, B., Almgren, P., Tuomi, T., Forsen, B., Latho, K., Nissen, M. et al. Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care 24(4):683-689, 2001
DOI
ScienceOn
|
29 |
Executive Summary of the Third report of the National Cholesterol Education program(NCEP) Expert Panel on Detection, Evaluation, and treatment of high Blood cholesterol in Adults(Adult Treatment Pannel III). JAMA 28: 2486-2497, 2001
|
30 |
Castelli, W.P. The triglyceride issue: A view from framnigham. Am Heart J, 112(2):432-437, 1986
DOI
PUBMED
ScienceOn
|
31 |
Yan, J., Wo, X.D., Fan, C.L. et al. Effects of total flavonoids in hawthorn leaves on PPAR- , PPRE pathway regulatory system. Chni Pharm J(chin) 40(8):625-628, 2005
|
32 |
Korea National Statistical Office. Statistical analysis, Cause of death. www.nso.go.kr.
|
33 |
Cai, X.J. Observation of Huazhuo Jiangzhi Decoction in treating 80 patients with hyperlipidemia. Shaanxi J Tradit Chin Med(chin). 25(2):35-36, 2003
|